Chang K - Search Results

1

Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.

Chang K, Pastan I, Willingham MC. Chang K, et al. Int J Cancer. 1992 Feb 1;50(3):373-81. doi: 10.1002/ijc.2910500308. Int J Cancer. 1992. PMID: 1735605

2

The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.

Chang KE, Wei BR, Madigan JP, Hall MD, Simpson RM, Zhuang Z, Gottesman MM. Chang KE, et al. Mol Cancer Ther. 2015 Jan;14(1):90-100. doi: 10.1158/1535-7163.MCT-14-0496. Epub 2014 Nov 5. Mol Cancer Ther. 2015. PMID: 25376608 Free PMC article.

3

Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.

Chang K, Pastan I. Chang K, et al. Int J Cancer. 1994 Apr 1;57(1):90-7. doi: 10.1002/ijc.2910570117. Int J Cancer. 1994. PMID: 8150545

4

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Chang K, Pastan I. Chang K, et al. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):136-40. doi: 10.1073/pnas.93.1.136. Proc Natl Acad Sci U S A. 1996. PMID: 8552591 Free PMC article.

5

Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.

Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Chang K, et al. Cancer Res. 1992 Jan 1;52(1):181-6. Cancer Res. 1992. PMID: 1727378

6

Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors.

Chang K, Ding I, Kern FG, Willingham MC. Chang K, et al. J Histochem Cytochem. 1991 Sep;39(9):1281-7. doi: 10.1177/39.9.1680897. J Histochem Cytochem. 1991. PMID: 1680897

7

Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas.

Chang K, Pastan I, Willingham MC. Chang K, et al. Int J Cancer. 1992 Jun 19;51(4):548-54. doi: 10.1002/ijc.2910510408. Int J Cancer. 1992. PMID: 1351045

8

Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma.

Chang K, Pai LH, Pass H, Pogrebniak HW, Tsao MS, Pastan I, Willingham MC. Chang K, et al. Am J Surg Pathol. 1992 Mar;16(3):259-68. doi: 10.1097/00000478-199203000-00006. Am J Surg Pathol. 1992. PMID: 1599018

9

Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancers.

Brinkmann U, Webber K, Di Carlo A, Beers R, Chowdhury P, Chang K, Chaudhary V, Gallo M, Pastan I. Brinkmann U, et al. Among authors: chang k. Int J Cancer. 1997 May 16;71(4):638-44. doi: 10.1002/(sici)1097-0215(19970516)71:4<638::aid-ijc21>3.0.co;2-6. Int J Cancer. 1997. PMID: 9178820

10

Isolation of anti-mesothelin antibodies from a phage display library.

Chowdhury PS, Chang K, Pastan I. Chowdhury PS, et al. Among authors: chang k. Mol Immunol. 1997 Jan;34(1):9-20. doi: 10.1016/s0161-5890(97)00011-4. Mol Immunol. 1997. PMID: 9182872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results